We can’t show the full text here under this license.
Abstract
Essence
EGCG reduced experimental vascular aging markers by activating SIRT1-linked and suppressing .
Evidence
Preclinical in vitro endothelial-cell senescence experiments and in vivo mouse studies reported less senescence signaling, lower aortic SA-beta-gal staining, and reduced pulse wave velocity in the EGCG group compared with controls.
Caveat
The evidence comes from doxorubicin-induced cell senescence and mouse models, with no human vascular aging outcomes reported.
Simplified